Differential regulatory mechanisms of gut-derived SCFAs (acetate, propionate, butyrate) on the pulmonary TLR2 signaling pathway and their roles in the inflammatory balance of bacterial pneumonia

肠道来源的短链脂肪酸(乙酸、丙酸、丁酸)对肺部TLR2信号通路差异性调控机制及其在细菌性肺炎炎症平衡中的作用

阅读:1

Abstract

Gut microbiota-derived short-chain fatty acids (SCFAs), key mediators in gut-lung axis interactions, profoundly influence pulmonary immune homeostasis. Toll-like receptor 2 (TLR2) is crucial for initiating innate immunity against bacterial pneumonia by recognizing bacterial molecular patterns, but its signaling requires precise regulation to balance pathogen clearance and prevent excessive inflammation-induced tissue damage. The major SCFAs-acetate, propionate, and butyrate-modulate immune responses via distinct mechanisms, including G protein-coupled receptor (GPR) activation and histone deacetylase (HDAC) inhibition. However, direct evidence on how these SCFAs differentially regulate the pulmonary TLR2 signaling pathway in pulmonary cells is critically lacking. This review reviews current knowledge, examining TLR2's role in pulmonary immune defense and bacterial pneumonia, along with its regulatory network, and the molecular details of SCFA immunomodulation through GPR activation and HDAC inhibition. Crucially, we propose and thoroughly discuss a central hypothesis based on indirect evidence and molecular understanding: acetate and propionate likely inhibit early TLR2 signaling activation via GPR-mediated rapid pathways, while butyrate predominantly promotes late-stage inflammation resolution and tissue homeostasis by remodeling gene expression through its HDAC inhibitory activity. We further analyze the potential biological significance of this postulated differential regulatory pattern in maintaining inflammatory balance during bacterial pneumonia. This review integrates literature and mechanistic analysis, highlights critical knowledge gaps in SCFA-pulmonary TLR2 axis research (such as lack of direct evidence, unclear in vivo differential effects, and local concentration influence), and outlines future research directions to deepen understanding of gut-lung axis-mediated pulmonary immune regulation, providing a theoretical foundation for innovative bacterial pneumonia prevention and treatment strategies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。